Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With Type 2 Diabetes: A Meta-Analysis

Overview of attention for article published in Frontiers in endocrinology, February 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (61st percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 7 X posts from 5 X users, with an upper bound of 14,978 followers.

RT @FrontEndocrinol: New Research: Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With…

RT @FrontEndocrinol: New Research: Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With…

RT @FrontEndocrinol: New Research: Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With…

RT @FrontEndocrinol: New Research: Sodium-Glucose Co-Transporter 2 Inhibitors for Non-Alcoholic Fatty Liver Disease in Asian Patients With…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.